Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities?

Bridget Hernandez1, Noelle K Hasson, Ramsey Cheung

  • 1Pharmacy Service, VA Palo Alto Health Care System, Palo Alto, California 94304, USA.

Insights

This study found high adherence to hepatitis A and B vaccination guidelines in chronic hepatitis C patients. Missed opportunities remain the primary barrier to complete vaccination coverage.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Vaccinology

Background:

  • Vaccination against hepatitis A virus (HAV) and hepatitis B virus (HBV) is recommended for patients with chronic hepatitis C (CHC).
  • Physician performance measures have been adopted to track vaccination rates in CHC patients.
  • This study evaluated adherence to these new vaccination performance measures.

Purpose of the Study:

  • To determine adherence to physician performance measures for HAV and HBV vaccination in patients with chronic hepatitis C.
  • To identify reasons for non-adherence to vaccination recommendations in this patient population.

Main Methods:

  • Retrospective analysis of serology and immunization records from 2000 to 2007.
  • Inclusion of 2,968 patients with detectable hepatitis C virus (HCV) RNA.
  • Calculation of vaccination performance measure adherence rates for HAV and HBV.

Main Results:

  • Overall adherence rates were 71% for HAV, 70% for HBV, and 62% for both.
  • Among susceptible patients, 74% received HAV vaccination and 71% received HBV vaccination.
  • Major reasons for non-adherence included missed opportunities (41%) and vaccination outside the healthcare system (22%).

Conclusions:

  • Adherence to HAV and HBV vaccination recommendations in CHC patients is high and improving.
  • Missed opportunities represent the main barrier to achieving optimal vaccination rates.
  • Selective vaccination strategies may be effective in specific populations, such as veterans.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Vaccinations01:51

Vaccinations

Overview
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...